Oncologists' attitudes towards prophylaxis of cancer associated venous thromboembolism: A prospective, descriptive study.
Esin Aysel KandemirAygin Bayraktar EkincioğluSaadettin KilickapPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Attitudes of oncologists towards thromboprophylaxis in cancer patients are consistent with previous studies in the literature. The respondents are aware of the venous thromboembolism risk of cancer patients, however raising awareness on both cancer-associated venous thromboembolism and current guideline recommendations is needed.